BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27063351)

  • 21. Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells.
    Yu XZ; Albert MH; Anasetti C
    J Immunol; 2006 Mar; 176(6):3383-90. PubMed ID: 16517706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
    Chiffoleau E; BĂ©riou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
    J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolongation of allograft survival by passenger donor regulatory T cells.
    Harper IG; Gjorgjimajkoska O; Siu JHY; Parmar J; Mulder A; Claas FHJ; Hosgood SA; Nicholson ML; Motallebzadeh R; Pettigrew GJ
    Am J Transplant; 2019 May; 19(5):1371-1379. PubMed ID: 30548563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of regulated upon activation normal T-cell expressed and secreted in a model of retransplantation acute rejection mediated by alloreactive memory CD4+ T cells.
    Zhou X; Shan Z; Liang H; Lin Z; Qiu S; Kuang F; Zhuang J; Qi Z
    Transplant Proc; 2013 Mar; 45(2):546-51. PubMed ID: 23498790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection.
    Young JS; Chen J; Miller ML; Vu V; Tian C; Moon JJ; Alegre ML; Sciammas R; Chong AS
    Am J Transplant; 2016 Aug; 16(8):2312-23. PubMed ID: 26928966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.
    Zhang QW; Kish DD; Fairchild RL
    J Immunol; 2003 Jun; 170(11):5530-7. PubMed ID: 12759430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of recipient C3aR1 signaling limits expansion and differentiation of alloreactive CD8
    Mathern DR; Horwitz JK; Heeger PS
    Am J Transplant; 2019 Jun; 19(6):1628-1640. PubMed ID: 30565852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.
    Lee MK; Huang X; Jarrett BP; Moore DJ; Desai NM; Moh Lian M; Markmann JW; Deng S; Frank A; Singer A; Velidedeoglu E; Caton AJ; Markmann AJ
    Transplantation; 2003 Apr; 75(8):1415-22. PubMed ID: 12717241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts.
    Gaughan A; Wang J; Pelletier RP; Nadasdy T; Brodsky S; Roy S; Lodder M; Bobek D; Mofatt-Bruce S; Fairchild RL; Henry ML; Hadley GA
    Am J Transplant; 2014 Feb; 14(2):284-94. PubMed ID: 24410909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin allograft maintenance in a new synchimeric model system of tolerance.
    Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.
    Nozaki T; Amano H; Bickerstaff A; Orosz CG; Novick AC; Tanabe K; Fairchild RL
    J Immunol; 2007 Oct; 179(8):5238-45. PubMed ID: 17911609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.
    Smyth LA; Ratnasothy K; Moreau A; Alcock S; Sagoo P; Meader L; Tanriver Y; Buckland M; Lechler R; Lombardi G
    J Immunol; 2013 May; 190(9):4848-60. PubMed ID: 23536635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection.
    Brennan TV; Hoang V; Garrod KR; Liu FC; Hayden T; Kim J; Kang SM
    Transplantation; 2008 Jan; 85(2):247-55. PubMed ID: 18212630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
    Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
    PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantation tolerance in NF-kappaB-impaired mice is not due to regulation but is prevented by transgenic expression of Bcl-xL.
    Zhou P; Balin SJ; Mashayekhi M; Hwang KW; Palucki DA; Alegre ML
    J Immunol; 2005 Mar; 174(6):3447-53. PubMed ID: 15749879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells.
    Schenk S; Kish DD; He C; El-Sawy T; Chiffoleau E; Chen C; Wu Z; Sandner S; Gorbachev AV; Fukamachi K; Heeger PS; Sayegh MH; Turka LA; Fairchild RL
    J Immunol; 2005 Mar; 174(6):3741-8. PubMed ID: 15749914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.